[HTML] springer.comFull View

[HTML][HTML] Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

S Pabla, RJ Seager, E Van Roey, S Gao, C Hoefer… - Biomarker …, 2021 - Springer
Background Contemporary to the rapidly evolving landscape of cancer immunotherapy is
the equally changing understanding of immune tumor microenvironments (TMEs) which is …
被引用次数：25 相关文章
[HTML] biomedcentral.com

[HTML][HTML] Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

S Pabla, RJ Seager, E Van Roey… - Biomarker …, 2021 - biomarkerres.biomedcentral.com
Contemporary to the rapidly evolving landscape of cancer immunotherapy is the equally
changing understanding of immune tumor microenvironments (TMEs) which is crucial to the …

Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response.

S Pabla, RJ Seager, E Van Roey, S Gao… - Biomarker …, 2021 - go.gale.com
Background Contemporary to the rapidly evolving landscape of cancer immunotherapy is
the equally changing understanding of immune tumor microenvironments (TMEs) which is …

Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response.

S Pabla, RJ Seager, E Van Roey, S Gao… - Biomarker …, 2021 - europepmc.org
Background Contemporary to the rapidly evolving landscape of cancer immunotherapy is
the equally changing understanding of immune tumor microenvironments (TMEs) which is …
[HTML] nih.gov

[HTML][HTML] Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

S Pabla, RJ Seager, E Van Roey, S Gao… - Biomarker …, 2021 - ncbi.nlm.nih.gov
Background Contemporary to the rapidly evolving landscape of cancer immunotherapy is
the equally changing understanding of immune tumor microenvironments (TMEs) which is …

Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

S Pabla, RJ Seager, E Van Roey, S Gao… - Biomarker …, 2021 - search.proquest.com
Background Contemporary to the rapidly evolving landscape of cancer immunotherapy is
the equally changing understanding of immune tumor microenvironments (TMEs) which is …

Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

S Pabla, RJ Seager, E Van Roey, S Gao… - Biomarker …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Contemporary to the rapidly evolving landscape of cancer immunotherapy is
the equally changing understanding of immune tumor microenvironments (TMEs) which is …

Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response.

S Pabla, RJ Seager, E Van Roey, S Gao… - Biomarker …, 2021 - search.ebscohost.com
Background: Contemporary to the rapidly evolving landscape of cancer immunotherapy is
the equally changing understanding of immune tumor microenvironments (TMEs) which is …
[PDF] biomedcentral.com

[PDF][PDF] Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

S Pabla, RJ Seager, E Van Roey, S Gao… - 2021 - biomarkerres.biomedcentral.com
Background: Contemporary to the rapidly evolving landscape of cancer immunotherapy is
the equally changing understanding of immune tumor microenvironments (TMEs) which is …